Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Invasive staging of the mediastinum.

Literature DB >> 8109105

Invasive staging of the mediastinum.

M R Johnston¹.

Abstract

Mesh：

Year: 1993 PMID： 8109105 DOI： 10.1007/bf01659078

Source DB: PubMed Journal: World J Surg ISSN： 0364-2313 Impact factor: 3.352

Keyword Cloud
References

× No keyword cloud information.

22 in total

1. Use and prognostic value of staging mediastinoscopy in non-small-cell lung cancer.

Authors: M Albertucci; T R DeMeester; H M Golomb; H K MacMahon; J W Ryan; C Iascone
Journal: Surgery Date: 1987-10 Impact factor: 3.982

2. Clinical trials and meta-analysis. What do they do for us?

Authors: J P Kassirer
Journal: N Engl J Med Date: 1992-07-23 Impact factor: 91.245

3. Effect of histologically verified TNM stage on disease control in treated small cell carcinoma of the lung.

Authors: J A Meyer
Journal: Cancer Date: 1985-04-15 Impact factor: 6.860

4. Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung.

Authors: F G Pearson; N C DeLarue; R Ilves; T R Todd; J D Cooper
Journal: J Thorac Cardiovasc Surg Date: 1982-01 Impact factor: 5.209

5. Four-year follow-up on the Albany experience with intrapleural BCG in lung cancer.

Authors: M F McKneally; C Maver; L Lininger; H W Kausel; J B McIlduff; T M Older; E D Foster; R D Alley
Journal: J Thorac Cardiovasc Surg Date: 1981-04 Impact factor: 5.209

6. Lung cancer classification: the relationship of disease extent and cell type to survival in a clinical trials population.

Authors: C F Mountain; J M Lukeman; S P Hammar; D W Chamberlain; W F Coulson; D L Page; T A Victor; L H Weiland
Journal: J Surg Oncol Date: 1987-07 Impact factor: 3.454

Invasive staging of the mediastinum.

1. Use and prognostic value of staging mediastinoscopy in non-small-cell lung cancer.

2. Clinical trials and meta-analysis. What do they do for us?

3. Effect of histologically verified TNM stage on disease control in treated small cell carcinoma of the lung.

4. Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung.

5. Four-year follow-up on the Albany experience with intrapleural BCG in lung cancer.

6. Lung cancer classification: the relationship of disease extent and cell type to survival in a clinical trials population.

7. Diagnostic anterior mediastinotomy.

8. Clinical staging of patients with non-small cell lung cancer.

9. Prospective evaluation of mediastinoscopy for assessment of carcinoma of the lung.

10. Extended cervical mediastinoscopy. A single staging procedure for bronchogenic carcinoma of the left upper lobe.